CASP3 and hepatocellular carcinoma: Cell viability, cell proliferation, and caspase 3/7 activity assays demonstrated that HCC cells incubated with conditioned medium (CM) from M2-TAMs bore a significantly lower sensitivity to sorafenib (Fig. 1J–L).